Cardiovascular disease prevention
KEYWORDS: evidence, health, cvd, food, statement, programmes, study, evidence statement, risk, studies, community, cba, population, prevention, disease

others • Cost-effectiveness review: － Review 6: Prevention of cardiovascular disease at population level (Question 1; cost-effectiveness) Evidence statement R3.E1a indicates that the linked statement is numbered E1a in review 3. Evidence statement R5.12 indicates that the linked statement is numbered 12 in the primary research study (review 5). Evidence statement ER1 indicates that the linked statement is from expert report 1 (see additional evidence). Evidence statement CE1 indicates that the linked statement is numbered 1 in the cost-effectiveness review (review 6). ' The reviews, economic analysis and additional evidence are available. Where a recommendation is not directly taken from the evidence statements, but is inferred from the evidence, this is indicated by IDE (inference derived from the evidence). Where the PDG has considered other evidence, it is linked to the appropriate recommendation below. It is also listed in the additional evidence section of this appendix. This includes evidence used to develop other NICE guidelines and guidance. Recommendation 1: evidence statement R3.E1m; additional evidence ER3 Recommendation 2: evidence statements R3.E1b; R3E1h; R3.E1i; R3.E1j; R3.E1k; additional evidence ER10 Recommendation 3: additional evidence ER9; ER10 Recommendation 4: additional evidence ER4; ER6; CG43 (1) Recommendation 5: additional evidence ER4 Recommendation 6: additional evidence
